Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring women's preferences for diabetes prevention programs after gestational diabetes: A qualitative descriptive study.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Integrating the primary care perspective in the implementation of a diabetes prevention program for patients with recent gestational diabetes: a qualitative descriptive study.

BMC primary care·2026
Same author

Editorial: Patient-centered care: strengthening trust and communication in healthcare relationships.

Frontiers in medicine·2026
Same author

Assessing stakeholder readiness for implementation of a diabetes prevention programme for patients with recent gestational diabetes: a short report.

BMJ open quality·2026
Same author

Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage population.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same author

Applying machine learning and natural language processing to patient safety event reports: Identifying patterns of cardiovascular diagnostic errors.

PloS one·2026
Same journal

Preoperative Copper-to-Zinc Ratio and Postoperative Delirium After Hip Fracture Surgery: A Propensity Score-matched Cohort Study.

Orthopedics·2026
Same journal

Supracondylar Distal Femur Fracture Fixation: Early Experiences Comparing the Retrograde Nail With Locking Attachment Washer (LAW) Plate to Traditional Fixation Techniques.

Orthopedics·2026
Same journal

Intra-Articular Vancomycin Powder in Primary Total Knee Arthroplasty: A Retrospective Observational Study.

Orthopedics·2026
Same journal

Limb Salvage Versus Amputation for the Management of Primary Bone Tumors of the Upper Extremity: A Systematic Review.

Orthopedics·2026
Same journal

A Modified Keshishyan Index Demonstrates Three-dimensional Assessment of Asymmetry in Pediatric Pelvic Fractures.

Orthopedics·2026
Same journal

Planned Versus Intraoperative Vascular Surgery Consultations in Orthopedic Oncology.

Orthopedics·2026
See all related articles

Related Experiment Videos

Considering cardiovascular risks when using NSAIDs.

Kena Lanham1, Kelly Smith, Jeremy Flynn

  • 1University of Kentucky College of Pharmacy, Lexington, USA.

Orthopedics
|June 5, 2008
PubMed
Summary
This summary is machine-generated.

Healthcare providers and patients must discuss the cardiovascular risks associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Informed decisions are crucial for safe and effective pain management.

Related Experiment Videos

Area of Science:

  • Pharmacology
  • Cardiology
  • Patient Care

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
  • NSAIDs carry known cardiovascular risks.
  • Patient understanding of these risks is often limited.

Purpose of the Study:

  • To emphasize the importance of shared decision-making regarding NSAID use.
  • To highlight the need for patient education on NSAID-associated cardiovascular risks.

Main Methods:

  • This is a conceptual abstract, not a research study.
  • It synthesizes current understanding of NSAID risks and patient communication.

Main Results:

  • Informed patient decisions require a thorough understanding of potential cardiovascular risks.
  • Partnership between healthcare professionals and patients is key.

Conclusions:

  • Healthcare professionals must actively engage patients in discussions about NSAID risks.
  • Shared decision-making promotes safer NSAID utilization and mitigates cardiovascular events.